News

The posters demonstrate the capability of opti-ox technology to create any human cell.

bit.bio and Charles River Laboratories discuss the potential of precision reprogrammed human cells.

The piece talks about how bit.bio has "cracked the code" to grow human cells for a new era of regenerative medicine. 

bit.bio wins biotech of the year for the second time and CEO of the year for Mark Kotter.

The new Huntington’s disease human cell model is built with opti-ox reprogrammed glutamatergic neurons.

We were delighted to welcome CEO National Resilience Inc. Rahul Singhvi who visited our labs and office space.

Mark Kotter talks about the benefits of human cells for researchers, and how they can shape the future of drug development.

Leading experts across academia and industry share their thoughts into the challenges of in vitro cell models.